“…In fact, of the eight additional suspicious-appearing nodules visualized with NBI, only three were confirmed as malignant on final pathology, and none of the patients had surface malignancies identified with NBI that were not also seen with WL, even if in a different area ( 39 ). Aloisi et al ( 39 ) pointed out that further exploration of the use of NBI/3D WL imaging is required; this will now be further evaluated in a large randomized clinical trial with clinically relevant endpoints, with adequate power, quality control and measures ( 44 ). This will be according to the Idea, Development, Exploration, Assessment and Long-term Study (IDEAL) framework, describing 5 stages of evolution for new surgical therapeutic interventions.…”